BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 11831094)

  • 41. Pulsed dose-rate perioperative interstitial brachytherapy for soft tissue sarcomas of the extremities and skeletal muscles of the trunk.
    Lazzaro G; Lazzari R; Pelosi G; De Pas T; Mariani L; Mazzarol G; Sances D; Tosti G; Baldini F; Mosconi M; Tedeschi I; Viale G; Marsiglia H; Chiappa A; Vavassori A; Orecchia R; Testori A
    Ann Surg Oncol; 2005 Nov; 12(11):935-42. PubMed ID: 16195832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The management of patients with uterine sarcoma: a debated clinical challenge.
    Gadducci A; Cosio S; Romanini A; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Isolated limb perfusion with tumor necrosis factor-alpha and melphalan for patients with unresectable soft tissue sarcoma of the extremities.
    Noorda EM; Vrouenraets BC; Nieweg OE; van Coevorden F; van Slooten GW; Kroon BB
    Cancer; 2003 Oct; 98(7):1483-90. PubMed ID: 14508836
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgical management of sarcomas.
    Cheng EY
    Hematol Oncol Clin North Am; 2005 Jun; 19(3):451-70, v. PubMed ID: 15939191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Local control and survival in patients with soft tissue sarcomas treated with limb sparing surgery in combination with interstitial brachytherapy and external radiation.
    Muhic A; Hovgaard D; Mørk Petersen M; Daugaard S; Højlund Bech B; Roed H; Kjaer-Kristoffersen F; Aage Engelholm S
    Radiother Oncol; 2008 Sep; 88(3):382-7. PubMed ID: 18584905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of site on the therapeutic ratio of adjuvant radiotherapy in soft-tissue sarcoma of the extremity.
    Alektiar KM; Brennan MF; Singer S
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):202-8. PubMed ID: 16111590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interstitial brachytherapy for childhood soft tissue sarcoma.
    Laskar S; Bahl G; Ann Muckaden M; Puri A; Agarwal MG; Patil N; Shrivastava SK; Dinshaw KA
    Pediatr Blood Cancer; 2007 Oct; 49(5):649-55. PubMed ID: 17226842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center.
    Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK
    Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Soft-tissue sarcomas in the adult: news and trends].
    Bui NB; Stöckle E; Coindre JM; Lagarde P; Thomas L; Kind M
    Bull Cancer; 1998 Jan; 85(1):59-62. PubMed ID: 9752351
    [No Abstract]   [Full Text] [Related]  

  • 50. [Soft tissues sarcomas: good medical practices for an optimal management].
    Fayette J; Blay JY; Ray-Coquard I
    Cancer Radiother; 2006; 10(1-2):3-6. PubMed ID: 16324866
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Soft tissue sarcoma.
    Beech DJ
    J La State Med Soc; 1999 Jan; 151(1):33-41. PubMed ID: 11280813
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The future of sarcoma treatment.
    Biermann JS; Baker LH
    Semin Oncol; 1997 Oct; 24(5):592-7. PubMed ID: 9344326
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sarcomas of the head and neck region.
    Sturgis EM; Potter BO
    Curr Opin Oncol; 2003 May; 15(3):239-52. PubMed ID: 12778019
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nursing management of soft tissue sarcomas of the extremities.
    Carrubba DM; Jankowski CB; Kunsman J
    Clin J Oncol Nurs; 1999 Oct; 3(4):168-79. PubMed ID: 10703323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Optimal management of sarcomas of the breast: an update.
    Nizri E; Merimsky O; Lahat G
    Expert Rev Anticancer Ther; 2014 Jun; 14(6):705-10. PubMed ID: 24611696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neoadjuvant treatment of soft-tissue sarcoma: a multimodality approach.
    Reynoso D; Subbiah V; Trent JC; Guadagnolo BA; Lazar AJ; Benjamin R; Pollock RE; Ludwig JA
    J Surg Oncol; 2010 Mar; 101(4):327-33. PubMed ID: 20187067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Therapeutic options for synovial sarcoma].
    Deme D; Telekes A
    Orv Hetil; 2015 May; 156(22):875-80. PubMed ID: 26004546
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Soft tissue sarcomas: integrating primary care recognition with tertiary care center treatment.
    Rosenthal TC; Kraybill W
    Am Fam Physician; 1999 Aug; 60(2):567-72. PubMed ID: 10465231
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Brachytherapy and Function Preservation in the Localized Management of Soft Tissue Sarcomas of the Extremity.
    Harrison LB; Zelefsky MJ; Armstrong JG; Schupak KD; Brennan MF
    Semin Radiat Oncol; 1993 Oct; 3(4):260-269. PubMed ID: 10717078
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of soft tissue sarcoma: a focus on earlier stages.
    Gronchi A; Maki RG; Jones RL
    Future Oncol; 2017 Jan; 13(1s):13-21. PubMed ID: 27918202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.